Literature DB >> 15699149

Highly focused T cell responses in latent human pulmonary Mycobacterium tuberculosis infection.

Glenn Tully1, Cornelius Kortsik, Hanni Höhn, Ingeborg Zehbe, W E Hitzler, Claudia Neukirch, Kirsten Freitag, Klaus Kayser, Markus J Maeurer.   

Abstract

The elucidation of the molecular and immunological mechanisms mediating maintenance of latency in human tuberculosis aids to develop more effective vaccines and to define biologically meaningful markers for immune protection. We analyzed granuloma-associated lymphocytes (GALs) from human lung biopsies of five patients with latent Mycobacterium tuberculosis (MTB) infection. MTB CD4+ and CD8+ T cell response was highly focused in the lung, distinct from PBL, as assessed by TCR-CDR3 spectratyping coupled with a quantitative analysis of TCR VB frequencies. GALs produced IFN-gamma in response to autologous macrophages infected with MTB and to defined MTB-derived HLA-A2-presented peptides Ag85a242-250, Ag85b199-207, early secreted antigenic target 6 (ESAT-6)28-36, 19-kDa Ag88-97, or the HLA-DR-presented ESAT-6(1-20) epitope. Immune recognition of naturally processed and presented MTB epitopes or the peptide ESAT-6(1-20) could be linked to specific TCR VB families, and in two patients to unique T cell clones that constituted 19 and 27%, respectively, of the CD4+ and 17% of the CD8+ GAL population. In situ examination of MTB-reactive GALs by tetramer in situ staining and confocal laser-scanning microscopy consolidates the presence of MHC class I-restricted CD8+ T cells in MTB granuloma lesions and supports the notion that clonally expanded T cells are crucial in immune surveillance against MTB.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15699149     DOI: 10.4049/jimmunol.174.4.2174

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  39 in total

1.  CD46 engagement on human CD4+ T cells produces T regulatory type 1-like regulation of antimycobacterial T cell responses.

Authors:  Steven M Truscott; Getahun Abate; Jeffrey D Price; Claudia Kemper; John P Atkinson; Daniel F Hoft
Journal:  Infect Immun       Date:  2010-10-04       Impact factor: 3.441

2.  Persistent viral infection in humans can drive high frequency low-affinity T-cell expansions.

Authors:  Naeem Khan; Mark Cobbold; Joanne Cummerson; Paul A H Moss
Journal:  Immunology       Date:  2010-08-16       Impact factor: 7.397

3.  Higher human CD4 T cell response to novel Mycobacterium tuberculosis latency associated antigens Rv2660 and Rv2659 in latent infection compared with tuberculosis disease.

Authors:  Lerisa Govender; Brian Abel; E Jane Hughes; Thomas J Scriba; Benjamin M N Kagina; Marwou de Kock; Gerhard Walzl; Gillian Black; Ida Rosenkrands; Gregory D Hussey; Hassan Mahomed; Peter Andersen; Willem A Hanekom
Journal:  Vaccine       Date:  2010-10-23       Impact factor: 3.641

Review 4.  Orchestration of pulmonary T cell immunity during Mycobacterium tuberculosis infection: immunity interruptus.

Authors:  Samuel M Behar; Stephen M Carpenter; Matthew G Booty; Daniel L Barber; Pushpa Jayaraman
Journal:  Semin Immunol       Date:  2014-10-11       Impact factor: 11.130

5.  Exposure to a Mycobacterial Antigen, ESAT-6, Exacerbates Granulomatous and Fibrotic Changes in a Multiwall Carbon Nanotube Model of Chronic Pulmonary Disease.

Authors:  Anagha Malur; Barbara P Barna; Janki Patel; Matthew McPeek; Christopher J Wingard; Larry Dobbs; Mary Jane Thomassen
Journal:  J Nanomed Nanotechnol       Date:  2015-12-27

6.  Humoral immunity in tuberculin skin test anergy and its role in high-risk persons exposed to active tuberculosis.

Authors:  Liliana Encinales; Joaquin Zuñiga; Julio Granados-Montiel; Maria Yunis; Julio Granados; Ingrid Almeciga; Olga Clavijo; Carlos Awad; Vilma Collazos; María Inés Vargas-Rojas; José Luis Bañales-Mendez; Lilia Vazquez-Castañeda; Joel N Stern; Viviana Romero; Masha Fridkis-Hareli; Masha Frindkis-Hareli; Daniel Terreros; Marcelo Fernandez-Viña; Edmond J Yunis
Journal:  Mol Immunol       Date:  2009-12-09       Impact factor: 4.407

7.  Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8 T-cell responses.

Authors:  Rebecca Axelsson-Robertson; Frank Weichold; Donata Sizemore; Markus Wulf; Yasir A W Skeiky; Jerry Sadoff; Markus J Maeurer
Journal:  Immunology       Date:  2009-11-25       Impact factor: 7.397

Review 8.  Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity.

Authors:  Joshua S M Woodworth; Samuel M Behar
Journal:  Crit Rev Immunol       Date:  2006       Impact factor: 2.214

9.  Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells.

Authors:  Thomas J Scriba; Michele Tameris; Nazma Mansoor; Erica Smit; Linda van der Merwe; Fatima Isaacs; Alana Keyser; Sizulu Moyo; Nathaniel Brittain; Alison Lawrie; Sebastian Gelderbloem; Ashley Veldsman; Mark Hatherill; Anthony Hawkridge; Adrian V S Hill; Gregory D Hussey; Hassan Mahomed; Helen McShane; Willem A Hanekom
Journal:  Eur J Immunol       Date:  2010-01       Impact factor: 5.532

10.  DR*W201/P65 tetramer visualization of epitope-specific CD4 T-cell during M. tuberculosis infection and its resting memory pool after BCG vaccination.

Authors:  Huiyong Wei; Richard Wang; Zhuqing Yuan; Crystal Y Chen; Dan Huang; Lisa Halliday; Weihua Zhong; Gucheng Zeng; Yun Shen; Ling Shen; Yunqi Wang; Zheng W Chen
Journal:  PLoS One       Date:  2009-09-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.